Targeting BCMA in multiple myeloma: designs, challenges, and future directions by Yi Hu, Yuetao Xie, Xiaodong Wang, Lufeng Yang, He Geng, Zugang Yi, Yao Zhang, Lin Ma, Fang Chen

Subjects: Get full text

Recurrent Plasmacytomas after Allografting in a Patient with Multiple Myeloma by Allen N. Stawis, Diane Maennle, Moreno Festuccia, Zia Uddin, Benedetto Bruno

“…Extramedullary recurrence in multiple myeloma patients has been reported after both autologous and allogeneic hematopoietic cell transplantation and, more recently, after treatment with so-called new drugs with potent antimyeloma activity. …”
Get full text

Relapse of Multiple Myeloma Presenting as Extramedullary Plasmacytomas in Multiple Organs by Murat Köse, Ersida Buraniqi, Timur Selçuk Akpinar, Seyit Mehmet Kayacan, Tufan Tükek

“…Multiple myeloma is a neoplastic plasma cell disorder. …”
Get full text

Cytokine and Chemokine Profile in Patients with Multiple Myeloma Treated with Bortezomib by Paweł Robak, Edyta Węgłowska, Izabela Dróżdż, Damian Mikulski, Dariusz Jarych, Magdalena Ferlińska, Ewa Wawrzyniak, Małgorzata Misiewicz, Piotr Smolewski, Wojciech Fendler, Janusz Szemraj, Tadeusz Robak

“…The aim of the study was to determine the levels of selected cytokines and chemokines in the serum of multiple myeloma (MM) patients treated with bortezomib-based regimens. …”
Get full text

Sinusoidal Obstruction Syndrome (SOS) in Multiple Myeloma with Renal Failure by Urvi A. Shah, Sengottuvel Viswanathan, Beamon Agarwal, Aditi Shastri, Ioannis Mantzaris, Murali Janakiram, Noah Kornblum, Ira Braunschweig, Amit Verma, Yang Shi, John Reinus, Olga Derman

Get full text

Dural Plasmacytoma with Meningeal Myelomatosis in a Patient with Multiple Myeloma by Nieves Gascón, Héctor Pérez-Montero, Sandra Guardado, Rafael D’Ambrosi, María Ángeles Cabeza, José Fermín Pérez-Regadera

“…Here, we describe the case of a 66-year-old male diagnosed with multiple myeloma who presented with generalized tonic-clonic seizures. …”
Get full text

Secondary Primary Malignancies in Multiple Myeloma: An Old Nemesis Revisited by Jay Yang, Howard R. Terebelo, Jeffrey A. Zonder

Get full text

Synchronous multiple myeloma and lung adenocarcinoma: A clinical series by Fang Ye, Huan Wang, Ningning Li, Aijun Liu, Wenming Chen

Subjects: Get full text

IgD Multiple Myeloma Paraproteinemia as a Cause of Myositis by I. Colombo, M. E. Fruguglietti, L. Napoli, M. Sciacco, E. Tagliaferri, A. Della Volpe, V. Crugnola, N. Bresolin, M. Moggio, A. Prelle

“…A 48-years old man was diagnosed an IgD-k multiple myeloma (MM) at age 38 years for which he successfully underwent chemotherapy and bone marrow transplant. …”
Get full text

Hypergranular multiple myeloma with crystalline inclusions in young with 13q deletion by Ummiti Muniswari, Chinmayee Panigrahi, Sourav Kumar Mishra, Somanath Padhi

Get full text

Is There a Role for Daratumumab Retreatment in Patients with Relapsed/Refractory Multiple Myeloma? by Davor Galusic, Ivan Krecak, Viktor Blaslov, Andela Krstulovic Opara, Toni Valkovic, Sandra Basic Kinda

Subjects: “…multiple myeloma…”
Get full text

Effect of bortezomib on the treatment of multiple myeloma: a systematic review protocol by Vania dos Santos Nunes-Nogueira, Lucas Oliveira Cantadori, Rafael Dezen Gaiolla

“…Introduction Multiple myeloma (MM) is an incurable malignant neoplasm that accounts for approximately 1% of all cancers and 10% of haematological malignancies. …”
Get full text

Serum Proinflammatory Mediators at Different Periods of Therapy in Patients With Multiple Myeloma by Irfan Kuku, Mehmet Refik Bayraktar, Emin Kaya, Mehmet Ali Erkurt, Nihayet Bayraktar, Kerim Cıkım, Ismet Aydogdu

Get full text

Efficacy of Carfilzomib, Lenalidomide, and Dexamethasone for Extramedullary Intracranial Localization of Multiple Myeloma by Giuseppe Mele, Domenico Pastore

Get full text

Nonsecretory Multiple Myeloma and AL Amyloidosis Presenting with Nephrotic Range Proteinuria by Ozlem Beyler Kilic, Ali Kemal Oguz, Ihsan Ergun, Dilek Ertoy Baydar, Meltem Ayli

“…Nonsecretory multiple myeloma (NSMM) is the absence of a detectable monoclonal protein in serum and urine of a multiple myeloma (MM) patient and immunoglobulin light chain (AL) amyloidosis is a significantly rare complication. …”
Get full text

Acute Liver Rejection in a Multiple Myeloma Patient Treated with Lenalidomide by Iuliana Vaxman, John Eaton, Hee Eun Lee, Morie A. Gertz

“…Herein we present a patient that underwent a liver transplant due to primary biliary cholangitis (PBC) and after 9 years developed multiple myeloma. Following the cessation of mycophenolate mofetil and 2 weeks after lenalidomide treatment was started, the patient experienced acute cellular rejection. …”
Get full text

Functional Comparison between Healthy and Multiple Myeloma Adipose Stromal Cells by Nicolas Espagnolle, Benjamin Hebraud, Jean-Gérard Descamps, Mélanie Gadelorge, Marie-Véronique Joubert, Laura Do Souto Ferreira, Murielle Roussel, Anne Huynh, Luc Sensébé, Louis Casteilla, Michel Attal, Hervé Avet-Loiseau, Frederic Deschaseaux, Philippe Bourin, Jill Corre

“…Multiple myeloma (MM) is an incurable B cell neoplasia characterized by the accumulation of tumor plasma cells within the bone marrow (BM). …”
Get full text

A Case of Multiple Myeloma Coexisting with Primary Hyperparathyroidism and Review of the Literature by Nasir Hussain, Moona Khan, Aparna Natarajan, Mubeenkhan Mohammedabdul, Usman Mustafa, Kalpana Yedulla, Aibek E. Mirrakhimov

“…Hypercalcemia is a common medical problem with an estimated prevalence of 15% among hospitalized patients. Multiple myeloma (MM) and primary hyperparathyroidism (PHPT) are among the most common causes of hypercalcemia but coexistence of both pathologic processes in a patient is an extremely rare phenomenon. …”
Get full text

Factitiously Elevated Total Triiodothyronine in a Euthyroid Patient with Multiple Myeloma by Kaushik Mandal, Damilola Ashorobi, Alice Lee, Huijuan Liao, Salini C. Kumar, David S. Rosenthal

“…Sporadic reports of factitious elevations of thyroid hormones related to laboratory interference from autoantibodies and multiple myeloma paraproteins have appeared in the literature. …”
Get full text

Diagnosis and Treatment of Bone Disease in Multiple Myeloma: Spotlight on Spinal Involvement by Patrizia Tosi

“…Bone disease is observed in almost 80% of newly diagnosed symptomatic multiple myeloma patients, and spine is the bone site that is more frequently affected by myeloma-induced osteoporosis, osteolyses, or compression fractures. …”
Get full text